H L Figge - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Human Pathology|September 1, 1995

E-cadherin expression in papillary transitional cell carcinoma of the urinary bladderJ S Ross, A D del Rosario, H L Figge, et al.

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1994

Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinomaB V Kallakury, T A Jennings, J S Ross, et al.

Journal of Clinical Pharmacology|December 1, 1988

Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in manH L Figge, J Figge, P F Souney, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1996

Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulationB V Kallakury, J Figge, B Leibovich, et al.

Cancer|March 15, 1994

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53R A Ambros, P A Vigna, J Figge, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 1994

E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcomeJ S Ross, H L Figge, H X Bui, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Human Pathology|September 1, 1995

E-cadherin expression in papillary transitional cell carcinoma of the urinary bladderJ S Ross, A D del Rosario, H L Figge, et al.

Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1994

Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinomaB V Kallakury, T A Jennings, J S Ross, et al.

Journal of Clinical Pharmacology|December 1, 1988

Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in manH L Figge, J Figge, P F Souney, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1996

Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulationB V Kallakury, J Figge, B Leibovich, et al.

Cancer|March 15, 1994

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53R A Ambros, P A Vigna, J Figge, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 1994

E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcomeJ S Ross, H L Figge, H X Bui, et al.

Pageof 2